Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase I: Maximum tolerated dose (MTD) and the recommended dose (RD) of L19IL2 for phase II when administered in combination with a fixed dose of DTIC. Phase II: Antitumor activity in terms of best objective response rate (BORR) in patients treated with L19-IL2 at RD in combination with DTIC versus patients treated with DTIC monotherapy.
Critère d'inclusion
- Metastatic Melanoma stage IV